ArticleJournal of substance abuse treatment2022

Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic.

Kristin M Mattocks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.